Alexander Fabian

#Head and #neck #cancer #survivors have specific long‐term health‐related #quality of #life restrictions: See data of this large multinational @EORTC study: onlinelibrary.wiley.com/doi/10.1002/ij… #headneckcancer #QOL #fightcancer @UniJena @uniklinik_jena

#bladderpreservation is in vogue! Is #immunotherapy a value addition to modern TMT, or a 'rebel without a cause'? NEW editorial to check out (FREE link👇🏽)Thanks to @IJROBP for the invite and @achoud72 for the motivation 🙏🏽🤩 #bladdercancer #bcsm authors.elsevier.com/a/1iBh%7E1Hx52…

#jDEGRO ist zu Gast am Zentrum für Strahlentherapie und Radioonkologie: Eine tolle Veranstaltung mit hervorragenden Facharzt-Crashkursen von Prof. Kerstin Borgmann, Prof. Juliane Hörner-Rieber, Prof. Dirk Vordermark und PD David Krug - und praktischen Kursen vom Team des Zentrums

High patient satisfaction👍 with #radiotherapy care in Germany. Check out this yDEGRO analysis of >1000 patients with #cancer treated in 11 centres. 🗞️📫: bit.ly/3uqtM9e 🙏 @RuehleAlex @DavidKrugMD @BoekeSimon @degro_ev @Chrisandfink @UKHD_radonc @RadOnc_UKF & many more

🗞️Hot off the press: A Multicenter Evaluation of Different Chemotherapy Regimens in Older Adults With Head and Neck Squamous Cell Carcinoma Undergoing Definitive Chemoradiation Published in the @IJROBP redjournal.org/article/S0360-… A 🧵 (1/n)

I feel delighted to share the results of our international project about the value of concomitant systemic treatment in older adults with head and neck squamous cell carcinoma (HNSCC) undergoing radiotherapy. ja.ma/3ElNsx5 via @JAMANetworkOpen part of @JAMANetwork A🧵

Am 17. und 18.11. ist es wieder soweit: Der diesjährige jDEGRO-Retreat findet 2023 in Bremen statt. Crashkurs Facharztwissen, Konturierungskurs, Workshop Forschung sowie Vortrag zur Niederlassung - für alle ist was dabei! Anmeldung bis 10.11. unter jd@degro.org

An astute analysis of the disconnect between evidence and practice in oncology by Prof Peter Hoskin in @BMJOncology Many, many nails hit on the head... @MCRCnews @ESTRO_RT @RCRadiologists @ASTRO_org bmjoncology.bmj.com/content/2/1/e0…

NOW OF: The (DARS) phase 3 RCT investigates if dysphagia-optimised intensity-modulated radiotherapy (IMRT) reduces radiation dose to the dysphagia and aspiration related structures and improves swallowing function compared with standard IMRT. #hncsm thelancet.com/journals/lanon…

👉Nearly 2/3 of patients with #cancer reported significant distress at the end of #radiotherapy in this young DEGRO analysis. Let's keep up screening & support. bit.ly/42tne5A @RuehleAlex @DavidKrugMD @BoekeSimon @degro_ev @Chrisandfink @UKHD_radonc @RadOnc_UKF

👉 Quality of life after palliative #radiotherapy for #headandneckcancer : check our prospective findings recently published in Clinical and Translational Radiation Oncology ctro.science/article/S2405-…

41% der Patient:innen unter #Strahlentherapie berichten subjektive finanzielle Belastung💵. Mehr als angenommen. 👉Deutschlandweite Studie der #jDEGRO mit >1000 Patient:innen beleuchtet Häufigkeit und Risikofaktoren: 🔗sciencedirect.com/science/articl…

@RuehleAlex Fantastic collaborative work led to these astonishing results: FinTox was more common than hypothesized. Let's be more aware of this issue in practice! #Cancer #financialtoxicity #SuppOnc

☢️▶️💵 Check this prospective cross-sectional study about excess financial strain and financial toxicity in cancer patients undergoing radiotherapy in Germany. Congrats especially to Alexander Fabian who concipated and led this young DEGRO study. sciencedirect.com/science/articl…